title: Whither peptide receptor radionuclide therapy for neuroendocrine tumors: an Einsteinian view of the facts and myths.
authors.affiliation: Department of Nuclear Medicine, Campus Virchow-Klinikum, Charité University Hospital, Berlin, Germany, vikas.prasad@charite.de.
authors.forename: Vikas
authors.initials: V
authors.lastname: Prasad
authors.forename: Lisa
authors.initials: L
authors.lastname: Bodei
authors.forename: Mark
authors.initials: M
authors.lastname: Kidd
authors.forename: Irvin M
authors.initials: IM
authors.lastname: Modlin
mesh_terms: D006801:Humans; D018358:Neuroendocrine Tumors / Q000532:radiotherapy*; D019275:Radiopharmaceuticals / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D018000:Receptors, Peptide / Q000819:agonists / Q000037:antagonists & inhibitors / Q000378:metabolism*
chemical_list: D019275:Radiopharmaceuticals; D018000:Receptors, Peptide